Immunomodulation for treatment of drug and device refractory gastroparesis

Conclusions Immunomodulatory therapy shows positive outcomes in improving vomiting symptom in some gastroparetic patients who have coexisting positive autoimmune profiles. This preliminary data suggests the need for further investigations in immunotherapy targeted to patients with gastroparetic symptoms refractory to approved drug and device therapies.
Source: Results in Immunology - Category: Allergy & Immunology Source Type: research